• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DOT1L-AF10 复合物的结构与功能分析揭示了 MLL-AF10 相关白血病发病机制的机理见解。

Structural and functional analysis of the DOT1L-AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis.

机构信息

Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.

Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.

出版信息

Genes Dev. 2018 Mar 1;32(5-6):341-346. doi: 10.1101/gad.311639.118. Epub 2018 Mar 21.

DOI:10.1101/gad.311639.118
PMID:29563185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5900708/
Abstract

The mixed-lineage leukemia (MLL)-AF10 fusion oncoprotein recruits DOT1L to the homeobox A () gene cluster through its octapeptide motif leucine zipper (OM-LZ), thereby inducing and maintaining the MLL-AF10-associated leukemogenesis. However, the recognition mechanism between DOT1L and MLL-AF10 is unclear. Here, we present the crystal structures of both apo AF10 and its complex with the coiled-coil domain of DOT1L. Disruption of the DOT1L-AF10 interface abrogates MLL-AF10-associated leukemic transformation. We further show that zinc stabilizes the DOT1L-AF10 complex and may be involved in the regulation of the gene expression. Our studies may also pave the way for the rational design of therapeutic drugs against -rearranged leukemia.

摘要

混合谱系白血病(MLL)-AF10 融合癌蛋白通过其八肽基序亮氨酸拉链(OM-LZ)募集 DOT1L 到同源盒 A()基因簇,从而诱导和维持 MLL-AF10 相关的白血病发生。然而,DOT1L 和 MLL-AF10 之间的识别机制尚不清楚。在这里,我们展示了 apo AF10 及其与 DOT1L 卷曲螺旋结构域复合物的晶体结构。破坏 DOT1L-AF10 界面可消除 MLL-AF10 相关的白血病转化。我们进一步表明,锌稳定 DOT1L-AF10 复合物,并且可能参与调节基因的表达。我们的研究也可能为针对基因重排白血病的合理设计治疗药物铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/98c9c088843c/341f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/e0f0f07cbd6b/341f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/1f7ddface6d1/341f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/d3fdfbf202ab/341f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/98c9c088843c/341f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/e0f0f07cbd6b/341f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/1f7ddface6d1/341f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/d3fdfbf202ab/341f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5977/5900708/98c9c088843c/341f04.jpg

相似文献

1
Structural and functional analysis of the DOT1L-AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis.DOT1L-AF10 复合物的结构与功能分析揭示了 MLL-AF10 相关白血病发病机制的机理见解。
Genes Dev. 2018 Mar 1;32(5-6):341-346. doi: 10.1101/gad.311639.118. Epub 2018 Mar 21.
2
A higher-order configuration of the heterodimeric DOT1L-AF10 coiled-coil domains potentiates their leukemogenenic activity.同源二聚体 DOT1L-AF10 卷曲螺旋结构域的高级别构象增强了它们的致白血病活性。
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):19917-19923. doi: 10.1073/pnas.1904672116. Epub 2019 Sep 16.
3
Structural characteristics of coiled-coil regions in AF10-DOT1L and AF10-inhibitory peptide complex.AF10-DOT1L与AF10抑制肽复合物中卷曲螺旋区域的结构特征。
J Leukoc Biol. 2021 Dec;110(6):1091-1099. doi: 10.1002/JLB.1MA0421-010R. Epub 2021 May 16.
4
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.DOT1L,即 H3K79 甲基转移酶,是 MLL-AF9 介导白血病发生所必需的。
Blood. 2011 Jun 23;117(25):6912-22. doi: 10.1182/blood-2011-02-334359. Epub 2011 Apr 26.
5
Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.在 MLL/AF10(OM-LZ) 和致癌性 KRAS 协同诱导的小鼠骨髓移植模型中,Gpr125 参与髓样肉瘤的形成。
Int J Cancer. 2013 Oct 15;133(8):1792-802. doi: 10.1002/ijc.28195. Epub 2013 May 7.
6
hDOT1L links histone methylation to leukemogenesis.hDOT1L将组蛋白甲基化与白血病发生联系起来。
Cell. 2005 Apr 22;121(2):167-78. doi: 10.1016/j.cell.2005.02.020.
7
Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.AF4和DOT1L协同激活基因驱动MLL重排白血病。
J Clin Invest. 2017 May 1;127(5):1918-1931. doi: 10.1172/JCI91406. Epub 2017 Apr 10.
8
Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.靶向干扰端粒沉默 1 样蛋白(DOT1L)募集:鉴定 DOT1L 与混合谱系白血病(MLL)融合蛋白的相互作用。
J Biol Chem. 2013 Oct 18;288(42):30585-30596. doi: 10.1074/jbc.M113.457135. Epub 2013 Sep 1.
9
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.AF10亮氨酸拉链是MLL-AF10诱导髓系祖细胞白血病转化所必需的。
Blood. 2002 May 15;99(10):3780-5. doi: 10.1182/blood.v99.10.3780.
10
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.通过遗传灭活或药理学抑制 H3K79 甲基转移酶 Dot1l 来消除 MLL-AF10 和 CALM-AF10 介导的转化。
Leukemia. 2013 Apr;27(4):813-22. doi: 10.1038/leu.2012.327. Epub 2012 Nov 9.

引用本文的文献

1
Targeting the Menin-KMT2A interaction in leukemia: Lessons learned and future directions.靶向白血病中Menin-KMT2A相互作用:经验教训与未来方向
Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35332.
2
Loss of DOT1L function disrupts neuronal transcription, animal behavior, and leads to a novel neurodevelopmental disorder.DOT1L功能丧失会破坏神经元转录、动物行为,并导致一种新型神经发育障碍。
medRxiv. 2024 Nov 2:2024.10.31.24314716. doi: 10.1101/2024.10.31.24314716.
3
The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.

本文引用的文献

1
Evolution of AF6-RAS association and its implications in mixed-lineage leukemia.AF6与RAS关联的演变及其在混合谱系白血病中的意义。
Nat Commun. 2017 Oct 23;8(1):1099. doi: 10.1038/s41467-017-01326-5.
2
Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia.MLL旁系同源物在MLL重排白血病中的矛盾效应
Cancer Cell. 2017 Jun 12;31(6):729-731. doi: 10.1016/j.ccell.2017.05.014.
3
Enhanced potency of bivalent small molecule gp41 inhibitors.二价小分子gp41抑制剂的效力增强
AF10 易位驱动的急性白血病中 PZP 结构域的作用。
Nat Commun. 2021 Jul 5;12(1):4130. doi: 10.1038/s41467-021-24418-9.
4
High-resolution characterization of gene function using single-cell CRISPR tiling screen.使用单细胞 CRISPR 平铺筛选技术对基因功能进行高分辨率表征。
Nat Commun. 2021 Jul 1;12(1):4063. doi: 10.1038/s41467-021-24324-0.
5
The language of chromatin modification in human cancers.人类癌症中染色质修饰的语言。
Nat Rev Cancer. 2021 Jul;21(7):413-430. doi: 10.1038/s41568-021-00357-x. Epub 2021 May 17.
6
A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia.一盒化学物质抑制 MEN1 肿瘤抑制基因促进白血病。
ChemMedChem. 2021 May 6;16(9):1391-1402. doi: 10.1002/cmdc.202000972. Epub 2021 Mar 10.
7
Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation.靶向髓系恶性肿瘤及其他疾病中的染色质复合物:从基础机制到临床创新。
Cells. 2020 Dec 21;9(12):2721. doi: 10.3390/cells9122721.
8
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia.HOXA10 的过表达与急性髓系白血病的不良预后相关。
BMC Cancer. 2020 Jun 22;20(1):586. doi: 10.1186/s12885-020-07088-6.
9
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.基于核苷为重点的文库的结构为基础的虚拟筛选鉴定 DOT1L 抑制剂。
Eur J Med Chem. 2020 Mar 1;189:112023. doi: 10.1016/j.ejmech.2019.112023. Epub 2020 Jan 2.
10
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment.DOT1L:正常染色质重塑及混合谱系白血病治疗中的关键靶点。
Epigenetics. 2020 May;15(5):439-453. doi: 10.1080/15592294.2019.1699991. Epub 2019 Dec 28.
Bioorg Med Chem. 2017 Jan 1;25(1):408-420. doi: 10.1016/j.bmc.2016.11.010. Epub 2016 Nov 19.
4
PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.PRDM16通过内在组蛋白甲基转移酶活性抑制MLL1r白血病。
Mol Cell. 2016 Apr 21;62(2):222-236. doi: 10.1016/j.molcel.2016.03.010. Epub 2016 Apr 14.
5
The molecular mechanics of mixed lineage leukemia.混合谱系白血病的分子力学。
Oncogene. 2016 Oct 6;35(40):5215-5223. doi: 10.1038/onc.2016.30. Epub 2016 Feb 29.
6
Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.DOT1L募集至MLL-AF9的程度决定了靶基因上H3K79二甲基化和三甲基化的水平以及转化潜能。
Cell Rep. 2015 May 5;11(5):808-20. doi: 10.1016/j.celrep.2015.04.004. Epub 2015 Apr 23.
7
AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.AF10 调节不同 AML 亚型中 H3K79 的渐进性甲基化和 HOX 基因表达。
Cancer Cell. 2014 Dec 8;26(6):896-908. doi: 10.1016/j.ccell.2014.10.009. Epub 2014 Nov 20.
8
Characterization and inhibition of AF10-mediated interaction.AF10 介导相互作用的表征和抑制。
J Pept Sci. 2014 Jun;20(6):385-97. doi: 10.1002/psc.2626. Epub 2014 Apr 1.
9
Zinc and human disease.锌与人类疾病。
Met Ions Life Sci. 2013;13:389-414. doi: 10.1007/978-94-007-7500-8_12.
10
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.通过遗传灭活或药理学抑制 H3K79 甲基转移酶 Dot1l 来消除 MLL-AF10 和 CALM-AF10 介导的转化。
Leukemia. 2013 Apr;27(4):813-22. doi: 10.1038/leu.2012.327. Epub 2012 Nov 9.